Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Azelis: Transparency Notification from UBS Group AG

businesswire.com
UBS The article is a regulatory notification regarding UBS Group AG's shareholding in Azelis Group NV. It details the number of shares and financial instruments held by UBS Group AG and its affiliates, and the threshold crossed. There is no information in the article that suggests a positive or negative outlook for UBS Group AG itself.

ANTWERP, Belgium--( BUSINESS WIRE)--Regulatory News:

In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV (Brussels:AZE) announces that on 18 November 2025, it has received a transparency notification from UBS Group AG.

1. Summary of the notification

On 12 November 2025, UBS Group AG (taking into account the holding of all its affiliates) owned 993,365 shares with voting rights, representing 0.41% of the total number of shares issued by the company (243,921,719), as well as 10,718,325 equivalent financial instruments, representing 4.39% of the voting rights issued by the company.

2. Content of the notification

Reason for the notification

Acquisition or disposal of voting securities or voting rights

Notification by

A parent undertaking or a controlling person

Persons subject to the notification requirement

Name

Address (for legal entities)

UBS Group AG

Bahnhofstrasse 45, 8001 Zürich

Date on which the threshold is crossed

12 November 2025

Threshold that is crossed (in %)

3%

Denominator

243,921,719

Notified Details

A) Voting rights

Previous

notification

After the transaction

# of voting

rights

# of voting rights

% of voting rights

Holders of voting rights

Linked to

securities

Not linked to

the securities

Linked to

securities

Not linked to

the securities

UBS Group AG

0

0

0.00%

0.00%

UBS AG

59,806

0

0.02%

0.00%

UBS Europe SE

18,286

0

0.01%

0.00%

UBS Switzerland AG

655,289

0

0.27%

0.00%

UBS Asset Management (Europe) S.A.

80,518

0

0.03%

0.00%

UBS Asset Management Life Limited

8,128

0

0.00%

0.00%

UBS Fund Management (Ireland) Ltd.

72

0

0.00%

0.00%

UBS Fund Management (Switzerland) AG

171,266

0

0.07%

0.00%

Subtotal

993,365

0.41%

TOTAL

993,365

0

0.41%

0.00%

B) Equivalent financial instruments

After the transaction

Holders of equivalent

financial instruments

Type of financial

instrument

Expiration

date

Exercise

period

or date

# of voting

rights that may

be acquired if

the instrument

is exercised

% of voting

rights

Settlement

UBS AG

Long Call Option

17/12/2027

177,000

0.07%

physical

UBS AG

Short Put Option

19/12/2025

500,000

0.20%

physical

UBS AG

Equity Swaps

28/03/2028

1,938

0.00%

cash

UBS AG

Right to Recall of Lent shares

At any time

257,118

0.11%

physical

UBS AG

Right to Substitute shares delivered as collaterals

At any time

154,759

0.06%

physical

UBS Switzerland AG

Right to Recall of Lent shares

At any time

64,793

0.03%

physical

UBS Switzerland AG

Right to Substitute shares delivered as collaterals

At any time

155,218

0.06%

physical

UBS Switzerland AG

Right of use over shares

At any time

7,446,832

3.05%

physical

UBS AG

Right of use over shares

At any time

1,224,167

0.50%

physical

UBS Securities LLC

Right of use over shares

At any time

675,000

0.28%

physical

UBS AG

Long Call Option

17/03/2028

61,500

0.03%

physical

TOTAL

10,718,325

4.39%

TOTAL (A & B)

# of voting

rights

% of voting

rights

CALCULATE

11,711,690

4.80%

Chain of controlled undertakings through which the holding is effectively held, if applicable

Please see full chain of control attached.

Additional information

The disclosure obligation arose due to the total indirect holdings of UBS Group AG in voting rights of Azelis Group NV, held directly by controlled undertakings, going above 3% on 12th November 2025.

3. Further information

The full transparency notification as well as this press release can be consulted on the Azelis Group NV’s website.

About Azelis

Azelis is the reference global innovation service provider in the speciality chemical and food ingredients industry present in 65 countries across the globe with over 4,300 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to more than 62,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.2 billion (2024). Azelis Group NV is listed on Euronext Brussels under ticker AZE and is included in the BEL20 and BEL®ESG indices.

Across our extensive network of more than 70 application laboratories, our award-winning teams help develop formulations and provide technical guidance throughout the customers’ product development process. We combine a global market reach with a local footprint to offer a reliable, integrated, and unique digital service to local customers and attractive business opportunities to principals. Top industry-rated by Sustainalytics, Azelis is a leader in sustainability. We believe in building and nurturing solid, honest, and transparent relationships with our people and partners.

Impact through ideas. Innovation through formulation.

www.azelis.com

Attachment – Chain of control

11. Information in relation to the person subject to the notification obligation – organizational chart

UBS Group AG

UBS AG

UBS Switzerland AG

-

UBS Group AG

UBS AG

UBS Europe SE

-

UBS Group AG

UBS AG

UBS Asset Management AG

UBS Asset Management (Europe) S.A.

-

UBS Group AG

UBS AG

UBS Asset Management AG

UBS Asset Management Holding (No. 2) Ltd

UBS Asset Management Holding Ltd

UBS Asset Management Life Ltd

-

UBS Group AG

UBS AG

UBS Fund Management (Ireland) Ltd.

-

UBS Group AG

UBS AG

UBS Asset Management AG

UBS Asset Management Switzerland AG

UBS Fund Management (Switzerland) AG

-

UBS Group AG

UBS AG

UBS Americas Holding LLC

UBS Americas Inc.

UBS Securities LLC